Persistence associated with the use of biologicals for the treatment of ankylosing spondylitis in the Brazilian public health system

被引：0
|
作者：
dos Santos A. Santos, Barbara Rodrigues Alvernaz [1 ]
Oliveira, Gerusa A. [1 ]
Morgado, Marina [1 ]
Brandao, Natalia Dias [1 ]
Guerra Junior, Augusto Afonso [1 ]
Alvares-Teodoro, Juliana [1 ]
机构：
[1] Univ Fed Minas Gerais, Fac Pharm, Belo Horizonte, Brazil
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
377
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [21] RESOURCE USE PATTERNS AND COSTS ASSOCIATED WITH THE TREATMENT OF MYELOFIBROSIS, POLYCYTHEMIA VERA AND ESSENTIAL TROMBOCYTHEMIA IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
    Alves, M. R.
    Teich, V
    Fahham, L.
    VALUE IN HEALTH, 2013, 16 (03) : A190 - A190
  • [22] COST-MINIMIZATION ANALYSIS OF BIOLOGICAL DRUGS IN THE TREATMENT OF SPONDYLOARTHRITIS (PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS) UNDER THE BRAZILIAN PRIVATE HEALTH SYSTEM PERSPECTIVE
    Scaccabarozzi, L.
    Asano, E.
    Monteiro, A. C.
    VALUE IN HEALTH, 2016, 19 (03) : A249 - A249
  • [23] THE IMPACT OF BIOLOGIC THERAPY VERSUS CONVENTIONAL TREATMENT ON THE COSTS OF ANKYLOSING SPONDYLITIS CHRONIC COMPLICATIONS UNDER THE PERSPECTIVE OF BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Menezes, F. G.
    Chibana, V
    Tolentino, A. C.
    Reis, F. H.
    VALUE IN HEALTH, 2015, 18 (07) : A641 - A641
  • [24] Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis
    Steiner, Martina
    Esteban-Ortega, Maria del Mar
    Thuissard-Vasallo, Israel
    Garcia-Lozano, Isabel
    Garcia-Gonzalez, Alejandro Javier
    Perez-Blazquez, Eugenio
    Sambricio, Javier
    Garcia-Aparicio, Angel
    Casco-Silva, Bruno Francisco
    Sanz-Sanz, Jesus
    Valdes-Sanz, Nuria
    Fernandez-Espartero, Cruz
    Diaz-Valle, Teresa
    Gurrea-Almela, Maria
    Fernandez-Melon, Julia
    Gomez-Resa, Maria
    Pato-Cour, Esperanza
    Diaz-Valle, David
    Mendez-Fernandez, Rosalia
    Navio, Teresa
    Moriche-Carretero, Manuel
    Munoz-Fernandez, Santiago
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2024, 30 (04) : 131 - 137
  • [25] FACTORS ASSOCIATED WITH STOPPING BIOLOGICAL TREATMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Iftimie, G.
    Buta, C.
    Groseanu, L.
    Ionescu, R.
    Opris-Belinski, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S68 - S68
  • [26] RHEUMATOID ARTHRITIS TREATMENT PROFILE IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
    Amaral, L. M.
    Alencar Junior, F. O.
    Fahham, L.
    Fernandes, R. A.
    Pepe, C.
    VALUE IN HEALTH, 2020, 23 : S232 - S232
  • [27] The Use of TNF- α Inhibitors in Active Ankylosing Spondylitis Treatment
    Zouris, Georgios
    Evangelopoulos, Dimitrios Stergios
    Benetos, Ioannis S.
    Vlamis, John
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [28] Treatment of Ankylosing Spondylitis by Primary Care Physicians and Rheumatologists in an Academic Health System: A Retrospective Study
    Ogdie--Beatty, Alexis
    Magrey, Marina
    Fitzsimmons, Robert
    Abdollahi, Shahrzad
    Biljan, Ana
    Saffore, Christopher
    Walsh, Jessica
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 276 - 279
  • [29] The incidence and prevalence of ankylosing spondylitis in Thailand using ministry of public health database
    Mahakkanukrauh, Ajanee
    Suwannaroj, Siraphop
    Pongkulkiat, Patnarin
    Onchan, Tippawan
    Foocharoen, Chingching
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [30] Low eligibility for hepatitis B treatment in the Brazilian public health system
    Oliveira Scarponi, Cristiane Faria
    Ferreira Pedrosa, Marco Antonio
    Gomes Mol, Marcos Paulo
    Mascarenhas Hardman, Michael John
    Greco, Dirceu Bartolomeu
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2022, 55
12345